TWO SIGMA ADVISERS, LP - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$7,805,000
+2.0%
401,265
-12.7%
0.02%0.0%
Q4 2017$7,650,000
-37.4%
459,465
-23.7%
0.02%
-40.0%
Q3 2017$12,228,000
-20.5%
602,365
-37.0%
0.04%
-31.4%
Q2 2017$15,387,000
+11.1%
955,727
-12.7%
0.05%
+13.3%
Q1 2017$13,850,000
-0.6%
1,094,829
+4.1%
0.04%
-15.1%
Q4 2016$13,930,000
+148.0%
1,051,318
+343.7%
0.05%
+120.8%
Q3 2016$5,616,000
+3.6%
236,949
+26.0%
0.02%
-14.3%
Q2 2016$5,420,000
-3.6%
188,049
+7.1%
0.03%
-9.7%
Q1 2016$5,624,000
-18.6%
175,649
+8.7%
0.03%
-24.4%
Q4 2015$6,909,000
+1808.6%
161,578
+1524.1%
0.04%
+1950.0%
Q3 2015$362,000
-85.0%
9,949
-81.0%
0.00%
-89.5%
Q2 2015$2,408,000
+16.1%
52,449
+18.5%
0.02%
+18.8%
Q1 2015$2,074,000
+12.0%
44,249
-24.3%
0.02%
+6.7%
Q4 2014$1,852,000
-51.4%
58,449
-63.7%
0.02%
-50.0%
Q3 2014$3,814,000
-34.4%
160,849
-17.0%
0.03%
-33.3%
Q2 2014$5,811,000
-19.8%
193,749
-29.4%
0.04%
-31.8%
Q1 2014$7,248,000
+6.3%
274,349
+1.2%
0.07%0.0%
Q4 2013$6,816,000
+168.7%
271,049
+119.0%
0.07%
+120.0%
Q3 2013$2,537,000123,7490.03%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders